News Posts List

BIO Anniversary Reflections: We’re Saving Lives at 25


This year the Biotechnology Innovation Organization (BIO) celebrates our 25th anniversary. It’s impossible to review BIO’s interactive historical timeline without reflecting with pride on the role we’ve played in shaping policy to save lives and promote the health of our planet.

ArunA Biomedical Launches New Class of Exosome Biologics to Treat Central Nervous System and Neurode


Company rapidly moving toward clinical development of cell-free biologic therapy as study published in Translational Stroke Research demonstrates human neural exosomes improve tissue and functional recovery in pre-clinical model

Shire files for FDA approval of a new plasma manufacturing facility in Covington, Georgia to support


Shire files for FDA approval of a new plasma manufacturing facility in Covington, Georgia to support growing Immunology franchise

BD Completes Bard Acquisition, Creating New Global Health Care Leader


FRANKLIN LAKES, N.J., Dec. 29, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of C. R. Bard, Inc. (NYSE: BCR), creating a new health care industry leader with approximately $16 billion in annualized revenue.

BIO Applauds House Passage of the Corporate Governance Reform and Transparency Act


Washington, DC (December 21, 2017) – Today, the Biotechnology Innovation Organization (BIO) applauds the House of Representatives for passing H.R. 4015, the Corporate Governance Reform and Transparency Act. This bipartisan bill, sponsored by Reps. Sean Duffy (R-WI) and Gregory Meeks (D-NY), was approved by a 238-182 vote.

AdvaMed Praises House Problem Solvers Bill to Repeal Medical Device Tax


WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker following introduction of legislation (HR. 4695) by the House Problem Solvers Caucus, which includes repeal of the medical device excise tax:

Steven Stice named National Academy of Inventors Fellow


The National Academy of Inventors has named a University of Georgia faculty member who is a leading researcher in regenerative medicine to the 2017 class of NAI Fellows. Steven Stice, Georgia Research Alliance Eminent Scholar and director of the UGA Regenerative Bioscience Center, joins an elite group of 912 innovators representing more than 250 prestigious research universities and governmental and nonprofit research institutions.

AdvaMed Statement on Device Tax Suspension


WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from AdvaMed President and CEO Scott Whitaker regarding the proposal in the U.S. House to extend the suspension of the medical device excise tax: “AdvaMed commends the leadership of House Ways & Means Committee Chairman Kevin Brady and Reps. Erik Paulsen and Jackie Walorski for their proposal to prevent this onerous tax from returning. A five-year suspension is an important first step to provide medical technology innovators with confidence that this tax will not go back into effect. With time running short, we urge Congress to adopt this suspension immediately. “During the current suspension, medtech companies have been able to reinvest millions that otherwise would have been lost to the tax into new jobs, capital improvements and R&D to fuel the next generation of life-changing technologies for patients. We are committed to continuing this reinvestment in innovation if the tax is suspended on a long-term basis going forward. “However, while we applaud this proposed five-year suspension, it is a only a first step toward the ultimate goal to fully repeal the medical device tax and unleash the full promise of job growth and medical innovation for American patients.”

Animal vaccine company expanding Athens footprint as part of $80M investment


Athens' health-care economy is getting a booster shot. Boehringer Ingelheim, a provider of animal health products for pets and livestock, said it will invest more than $80 million to expand its existing facilities in Athens and St. Joseph, Missouri to accommodate increased production of animal vaccines.

Gilead Sciences, Emory and others launch $100 million initiative to address HIV/AIDS crisis in South


A group of scientific institutions are teaming up to take aim at the growing HIV/AIDS crisis in the southern United States. Gilead Sciences Inc. (NYSE: GILD), Emory University Rollins School of Public Health, the Southern AIDS Coalition and the University of Houston Graduate College of Social Work on Dec. 4 announced the Gilead COMPASS Initiative, a $100 million commitment of financial resources and support for organizations working to end HIV/AIDS.

Previous  |  1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  |  9  |  10  |  11  |  12  |  13  |  14  |  15  |  16  |  17  |  18  |  19  |  20  |  21  |  22  |  23  |  24  |  25  |  Next
Neon CRM by Neon One